Inhibitor of α-glucosidase (EC 3.2.1.20). The peptide EAGVD had α-glucosidase inhibitory activity with an IC50 of > 150.0 umol/l and α-amylase inhibitory activity with an IC50 of 110.0 ± 6.2 umol/l, the results revealed that the peptide EAGVD was a potential anti-diabetic inhibitor. Table 1 α-Glucosidase and α-amylase inhibitory activities of the peptides
Peptide sequences
| α-Glucosidase inhibitory activity (IC50)
| α-amylase inhibitory activity (IC50) | KLPGF
| 59.5 ± 5.7 μmol/l
| 120.0 ± 4.0 μmol/l | EVSGL
| > 150.0 μmol/l | > 150.0 μmol/l | QITKPN
| > 150.0 μmol/l | > 150.0 μmol/l | AEAGVD
| > 150.0 μmol/l | > 150.0 μmol/l | EAGVD
| > 150.0 μmol/l | 110.0 ± 6.2 μmol/l | NVLQPS
| 100.0 ± 5.7 μmol/l | > 150.0 μmol/l | LEPINF
| > 150.0 μmol/l | > 150.0 μmol/l | ANENIF
| > 150.0 μmol/l | > 150.0 μmol/l | |